MCID: THY054
MIFTS: 52

Thyrotoxic Periodic Paralysis

Categories: Endocrine diseases, Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Thyrotoxic Periodic Paralysis

MalaCards integrated aliases for Thyrotoxic Periodic Paralysis:

Name: Thyrotoxic Periodic Paralysis 53 59 29 6 40 73
Thyrotoxic Hypokalemic Periodic Paralysis 59 37

Characteristics:

Orphanet epidemiological data:

59
thyrotoxic periodic paralysis
Inheritance: Multigenic/multifactorial,Not applicable; Age of onset: Adult; Age of death: normal life expectancy;

Classifications:

Orphanet: 59  
Rare neurological diseases


Summaries for Thyrotoxic Periodic Paralysis

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 79102Disease definitionThyrotoxic periodic paralysis (TPP) is a rare neurological disease characterized by recurrent episodes of paralysis and hypokalemia during a thyrotoxic state.EpidemiologyIt is most common in Asian males (with male-to-female ratios ranging from 17:1 to 70:1) during the third decade of life: the annual incidence in Chinese and Japanese thyrotoxicosis patients is estimated at around 1/50, whereas it is estimated at 1-2/1,000 among non-Asian thyrotoxicosis patients.Clinical descriptionTPP manifests as recurrent episodes of acute muscular weakness of the four extremities that vary in severity from paresis to complete paralysis. Recovery occurs within 2-72 hours. Attacks typically occur at night and may be preceded by muscle cramps, aches and stiffness. Ocular, bulbar and respiratory involvement has also been reported but is rare. Attacks are triggered by ingestion of a high carbohydrate load or strenuous physical activity followed by a period of rest. Episodes only occur when patients are thyrotoxic but symptoms and classical signs of hyperthyroidism are often absent at the time of the first attack. TPP can occur in association with any cause of hyperthyroidism, but is most commonly associated with Graves' disease.EtiologyThe pathogenesis remains unclear. Genetic predisposition is thought to play a role in the pathogenesis of TPP and single nucleotide polymorphisms (SNPs) of the CACNA1S (1q32) and GABRA3 (Xq28) genes have been associated with TPP susceptibility in some Asian populations. Hypokalemia is the consequence of an extra- to intracellular potassium shift due to an increase in Na/K-ATPase pump activity, either as a direct response to thyroid hormone or indirectly via adrenergic stimulation, insulin or exercise.Diagnostic methodsBiochemical studies are essential for diagnosis, with mild-to-severe thyrotoxicosis and hypokalemia during attacks being the major findings. Other anomalies may include hypophosphatemia and hypomagnesemia, without changes in acid-base balance. EMG reveals myopathic changes during attacks and muscle excitability anomalies after a prolonged exercise test. ECG anomalies are also noted. Thyrotoxicosis is the key finding for distinguishing TPP from other causes of hypokalemic periodic paralysis (HOP), such as familial HOP (FHOP; see this term), and from other hypokalemic disorders with a transcellular potassium shift, and excessive renal potassium wasting or gastrointestinal losses.Differential diagnosisThe differential diagnosis may also include Guillain-Barré syndrome, transverse myelitis (see these terms), spinal cord compression and hysteria, as well as muscle weakness and fatigue associated with hyperthyroidism in patients with thyrotoxic myopathy or myasthenia gravis (see this term).Genetic counselingTPP usually occurs sporadicallyManagement and treatmentManagement of TPP includes definitive control of hyperthyroidism, prevention of attacks with propranolol and avoidance of precipitating factors. Potassium administration during attacks may prevent cardiac arrhythmias and hasten the recovery from paralysis.PrognosisThe prognosis for patients is good and TPP resolves when euthyroid status is achieved.Visit the Orphanet disease page for more resources.

MalaCards based summary : Thyrotoxic Periodic Paralysis, also known as thyrotoxic hypokalemic periodic paralysis, is related to thyrotoxic periodic paralysis 1 and hypokalemic periodic paralysis, type 1. An important gene associated with Thyrotoxic Periodic Paralysis is KCNJ18 (Potassium Voltage-Gated Channel Subfamily J Member 18), and among its related pathways/superpathways are Cardiac conduction and Collagen chain trimerization. The drugs Antibodies and Immunoglobulins have been mentioned in the context of this disorder. Affiliated tissues include thyroid, testes and heart, and related phenotypes are obesity and hyperhidrosis

Wikipedia : 76 Thyrotoxic periodic paralysis (TPP) is a condition featuring attacks of muscle weakness in the presence... more...

Related Diseases for Thyrotoxic Periodic Paralysis

Graphical network of the top 20 diseases related to Thyrotoxic Periodic Paralysis:



Diseases related to Thyrotoxic Periodic Paralysis

Symptoms & Phenotypes for Thyrotoxic Periodic Paralysis

Human phenotypes related to Thyrotoxic Periodic Paralysis:

59 32 (show all 42)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 obesity 59 32 hallmark (90%) Very frequent (99-80%) HP:0001513
2 hyperhidrosis 59 32 hallmark (90%) Very frequent (99-80%) HP:0000975
3 tremor 59 32 frequent (33%) Frequent (79-30%) HP:0001337
4 constipation 59 32 frequent (33%) Frequent (79-30%) HP:0002019
5 tetraplegia 59 32 hallmark (90%) Very frequent (99-80%) HP:0002445
6 emg abnormality 59 32 hallmark (90%) Very frequent (99-80%) HP:0003457
7 weight loss 59 32 frequent (33%) Frequent (79-30%) HP:0001824
8 prolonged qt interval 59 32 occasional (7.5%) Occasional (29-5%) HP:0001657
9 ophthalmoparesis 59 32 very rare (1%) Very rare (<4-1%) HP:0000597
10 muscle stiffness 59 32 frequent (33%) Frequent (79-30%) HP:0003552
11 periodic hypokalemic paresis 59 32 obligate (100%) Obligate (100%) HP:0008153
12 muscle cramps 59 32 frequent (33%) Frequent (79-30%) HP:0003394
13 hyporeflexia 59 32 frequent (33%) Frequent (79-30%) HP:0001265
14 episodic hypokalemia 59 32 obligate (100%) Obligate (100%) HP:0012726
15 episodic flaccid weakness 59 32 hallmark (90%) Very frequent (99-80%) HP:0003752
16 mildly elevated creatine phosphokinase 59 32 hallmark (90%) Very frequent (99-80%) HP:0008180
17 increased intramyocellular lipid droplets 59 32 hallmark (90%) Very frequent (99-80%) HP:0012240
18 exercise-induced muscle fatigue 59 32 frequent (33%) Frequent (79-30%) HP:0009020
19 postprandial hyperglycemia 59 32 frequent (33%) Frequent (79-30%) HP:0011998
20 late-onset proximal muscle weakness 59 32 occasional (7.5%) Occasional (29-5%) HP:0003694
21 respiratory paralysis 59 32 very rare (1%) Very rare (<4-1%) HP:0002203
22 lower limb muscle weakness 59 32 hallmark (90%) Very frequent (99-80%) HP:0007340
23 hyperkalemia 59 32 very rare (1%) Very rare (<4-1%) HP:0002153
24 urinary retention 59 32 frequent (33%) Frequent (79-30%) HP:0000016
25 graves disease 59 32 hallmark (90%) Very frequent (99-80%) HP:0100647
26 decreased urinary potassium 59 32 hallmark (90%) Very frequent (99-80%) HP:0012364
27 hypomagnesemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0002917
28 palpitations 59 32 hallmark (90%) Very frequent (99-80%) HP:0001962
29 ventricular fibrillation 59 32 occasional (7.5%) Occasional (29-5%) HP:0001663
30 rhabdomyolysis 59 32 frequent (33%) Frequent (79-30%) HP:0003201
31 second degree atrioventricular block 59 32 occasional (7.5%) Occasional (29-5%) HP:0011706
32 transient hypophosphatemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0008285
33 thyrotoxicosis with toxic multinodular goitre 59 32 hallmark (90%) Very frequent (99-80%) HP:0011785
34 thyrotoxicosis with toxic single thyroid nodule 59 32 hallmark (90%) Very frequent (99-80%) HP:0011786
35 shortened pr interval 59 32 occasional (7.5%) Occasional (29-5%) HP:0005165
36 abnormality of peripheral nerve conduction 59 Excluded (0%)
37 myotonia 59 Excluded (0%)
38 hyperthyroidism 59 Obligate (100%)
39 paralysis 59 Very frequent (99-80%)
40 abnormality of muscle fibers 59 Very frequent (99-80%)
41 impaired myocardial contractility 59 Excluded (0%)
42 thyrotoxicosis with diffuse goiter 59 Very frequent (99-80%)

MGI Mouse Phenotypes related to Thyrotoxic Periodic Paralysis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.56 ADRB2 ATP1A1 ATP1A2 ATP1B2 CACNA1S GABRA3
2 muscle MP:0005369 9.1 ADRB2 ATP1A1 ATP1A2 ATP1B1 CACNA1S KCNJ2

Drugs & Therapeutics for Thyrotoxic Periodic Paralysis

Drugs for Thyrotoxic Periodic Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Antibodies
2 Immunoglobulins

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Genetic and Morphological Analysis of Thyrotoxic Periodic Paralysis Unknown status NCT02287363
2 Genetic Analysis of Thyrotoxic Periodic Paralysis Completed NCT00443833

Search NIH Clinical Center for Thyrotoxic Periodic Paralysis

Genetic Tests for Thyrotoxic Periodic Paralysis

Genetic tests related to Thyrotoxic Periodic Paralysis:

# Genetic test Affiliating Genes
1 Thyrotoxic Periodic Paralysis 29 CACNA1S

Anatomical Context for Thyrotoxic Periodic Paralysis

MalaCards organs/tissues related to Thyrotoxic Periodic Paralysis:

41
Thyroid, Testes, Heart, Spinal Cord, Pituitary, Skeletal Muscle, Colon

Publications for Thyrotoxic Periodic Paralysis

Articles related to Thyrotoxic Periodic Paralysis:

(show top 50) (show all 267)
# Title Authors Year
1
ANNALS EXPRESS: Does thyrotoxic periodic paralysis have a genetic predisposition? A case report. ( 29886759 )
2018
2
An atypical presentation of high potassium renal secretion rate in a patient with thyrotoxic periodic paralysis: a case report. ( 29973184 )
2018
3
Thyrotoxic Periodic Paralysis and Cardiomyopathy in a Patient with Graves' Disease. ( 30131930 )
2018
4
Thyrotoxic periodic paralysis complicated by life-threatening acute hypercapnic respiratory failure in a Chinese male with painless thyroiditis. ( 30424987 )
2018
5
Lift Then Shift: Thyrotoxic Periodic Paralysis. ( 30201247 )
2018
6
Thyrotoxic periodic paralysis: case report and review of the literature. ( 30214699 )
2018
7
Hypokalemic thyrotoxic periodic paralysis. Report of one case. ( 30236802 )
2018
8
A Rare Case of Thyrotoxic Periodic Paralysis After Epidural Steroid Injection: A Case Report and Literature Review. ( 30531678 )
2018
9
Recognizing thyrotoxic hypokalemic periodic paralysis. ( 29278563 )
2018
10
Changing Management Guidelines in Thyrotoxic Hypokalemic Periodic Paralysis. ( 29871829 )
2018
11
Thyrotoxic Hypokalemic Periodic Paralysis. ( 29910553 )
2018
12
Thyrotoxic hypokalemic periodic paralysis. ( 30169664 )
2018
13
Thyrotoxic hypokalemic periodic paralysis: a life-threatening disorder in Asian men. ( 30305000 )
2018
14
Thyrotoxic periodic paralysis as an initial presentation of Graves' disease in a Saudi patient. ( 28630226 )
2017
15
Thyrotoxic periodic paralysis: A case report. ( 28293157 )
2017
16
Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to Thyrotoxic Periodic Paralysis. ( 28131627 )
2017
17
Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis. ( 29264532 )
2017
18
Thyrotoxic periodic paralysis: a case study and review of the literature. ( 28638574 )
2017
19
Thyrotoxic periodic paralysis: an unusual presentation of hyperthyroidism. ( 29219824 )
2017
20
Paralysis that easily reverses: a case of thyrotoxic periodic paralysis. ( 28137907 )
2017
21
A rare cause of thyrotoxic periodic paralysis: liquorice consumption. ( 28258118 )
2017
22
Normokalemic Thyrotoxic Periodic Paralysis with Acute Resolution in the Emergency Department. ( 29849397 )
2017
23
Is thyrotoxic periodic paralysis a disease caused by muscle membrane dysfunction? ( 28006864 )
2016
24
Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms. ( 27008341 )
2016
25
Thyrotoxic periodic paralysis- A case report. ( 27728174 )
2016
26
Thyrotoxic periodic paralysis-A case report. ( 27728198 )
2016
27
Thyrotoxic periodic paralysis. ( 27728745 )
2016
28
Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' Disease. ( 28008586 )
2016
29
Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease. ( 26676335 )
2016
30
A Case of Nonfatal Ventricular Arrhythmia Due to Thyrotoxic Periodic Paralysis in a Saudi Patient as an Initial Presentation of Graves' Disease. ( 26843815 )
2016
31
Thyrotoxic periodic paralysis: The immovable truth? A concise review of the literature. ( 27041083 )
2016
32
Lower-Extremity Weakness in a Teenager Due to Thyrotoxic Periodic Paralysis. ( 27955984 )
2016
33
Steroid-induced thyrotoxic periodic paralysis during Graves' ophthalmopathy treatment. ( 27566533 )
2016
34
Thyrotoxic Periodic Paralysis: A Puzzling Case of Chest Pain and Weakness. ( 26817428 )
2016
35
Myasthenia gravis accompanied by Graves' disease, thyrotoxic hypokalemic periodic paralysis and thymic hyperplasia. ( 27381127 )
2016
36
Thyrotoxic hypokalemic periodic paralysis. ( 27318366 )
2016
37
Thyrotoxic hypokalemic periodic paralysis in a Turkish patient presenting with a U wave on ECG. ( 27394710 )
2016
38
Normokalemic thyrotoxic periodic paralysis with preserved reflexes- a unique case report. ( 25859483 )
2015
39
A case of thyrotoxic periodic paralysis with respiratory failure in an African American woman. ( 25934725 )
2015
40
Thyrotoxic Periodic Paralysis: An Underdiagnosed and Under-recognized Condition. ( 26623197 )
2015
41
Thyrotoxic periodic paralysis in long standing graves' disease: an unusual presentation with normokalemia. ( 25839004 )
2015
42
The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis. ( 25885757 )
2015
43
A rare case of thyrotoxic periodic paralysis precipitated by hydrocortisone. ( 25810683 )
2015
44
Size of quadriceps femoris may contribute to thyrotoxic periodic paralysis. ( 26519100 )
2015
45
THYROTOXIC PERIODIC PARALYSIS, I^2-ADRENERGIC BRONCHODILATOR, AND INSULIN-AN INTERESTING INTERPLAY. ( 24742912 )
2014
46
Thyrotoxic periodic paralysis: an endocrine cause of paraparesis. ( 24906287 )
2014
47
Case of thyrotoxic periodic paralysis in a caucasian male and review of literature. ( 25484903 )
2014
48
Thyrotoxic periodic paralysis: clinical challenges. ( 24695373 )
2014
49
Thyrotoxic periodic paralysis triggered by I^2-adrenergic bronchodilators. ( 24852589 )
2014
50
Hypokalemia in thyrotoxic periodic paralysis: implication for nephrology practice. ( 24902491 )
2014

Variations for Thyrotoxic Periodic Paralysis

ClinVar genetic disease variations for Thyrotoxic Periodic Paralysis:

6 (show all 23)
# Gene Variation Type Significance SNP ID Assembly Location
1 KCNJ18 NM_001194958.2(KCNJ18): c.429delC (p.Ile144Serfs) deletion Pathogenic,risk factor rs527236153 GRCh38 Chromosome 17, 21703215: 21703215
2 KCNJ18 NM_001194958.2(KCNJ18): c.1061C> T (p.Thr354Met) single nucleotide variant Pathogenic,risk factor rs527236158 GRCh38 Chromosome 17, 21703847: 21703847
3 KCNJ18 NM_001194958.2(KCNJ18): c.1061C> T (p.Thr354Met) single nucleotide variant Pathogenic,risk factor rs527236158 GRCh37 Chromosome 17, 356212: 356212
4 KCNJ18 NM_001194958.2(KCNJ18): c.1097A> G (p.Lys366Arg) single nucleotide variant Pathogenic,risk factor rs527236159 GRCh38 Chromosome 17, 21703883: 21703883
5 KCNJ18 NM_001194958.2(KCNJ18): c.1097A> G (p.Lys366Arg) single nucleotide variant Pathogenic,risk factor rs527236159 GRCh37 Chromosome 17, 356248: 356248
6 CACNA1S NM_000069.2(CACNA1S): c.-476G> A single nucleotide variant risk factor rs2281845 GRCh37 Chromosome 1, 201081943: 201081943
7 CACNA1S NM_000069.2(CACNA1S): c.-476G> A single nucleotide variant risk factor rs2281845 GRCh38 Chromosome 1, 201112815: 201112815
8 CACNA1S NM_000069.2(CACNA1S): c.258+57G> A single nucleotide variant risk factor rs1325310 GRCh37 Chromosome 1, 201079235: 201079235
9 CACNA1S NM_000069.2(CACNA1S): c.258+57G> A single nucleotide variant risk factor rs1325310 GRCh38 Chromosome 1, 201110107: 201110107
10 CACNA1S NM_000069.2(CACNA1S): c.3414+67A> G single nucleotide variant risk factor rs28986463 GRCh38 Chromosome 1, 201060591: 201060591
11 CACNA1S NM_000069.2(CACNA1S): c.3414+67A> G single nucleotide variant risk factor rs28986463 GRCh37 Chromosome 1, 201029719: 201029719
12 KCNJ18 NM_001194958.2(KCNJ18): c.127C> T (p.Arg43Cys) single nucleotide variant Pathogenic rs527236151 GRCh37 Chromosome 17, 355278: 355278
13 KCNJ18 NM_001194958.2(KCNJ18): c.127C> T (p.Arg43Cys) single nucleotide variant Pathogenic rs527236151 GRCh38 Chromosome 17, 21702913: 21702913
14 KCNJ18 NM_001194958.2(KCNJ18): c.419C> T (p.Thr140Met) single nucleotide variant Pathogenic rs527236152 GRCh37 Chromosome 17, 355570: 355570
15 KCNJ18 NM_001194958.2(KCNJ18): c.419C> T (p.Thr140Met) single nucleotide variant Pathogenic rs527236152 GRCh38 Chromosome 17, 21703205: 21703205
16 KCNJ18 NM_001194958.2(KCNJ18): c.502G> A (p.Val168Met) single nucleotide variant Pathogenic rs527236154 GRCh37 Chromosome 17, 355653: 355653
17 KCNJ18 NM_001194958.2(KCNJ18): c.502G> A (p.Val168Met) single nucleotide variant Pathogenic rs527236154 GRCh38 Chromosome 17, 21703288: 21703288
18 KCNJ18 NM_001194958.2(KCNJ18): c.598G> C (p.Ala200Pro) single nucleotide variant Pathogenic rs527236155 GRCh37 Chromosome 17, 355749: 355749
19 KCNJ18 NM_001194958.2(KCNJ18): c.598G> C (p.Ala200Pro) single nucleotide variant Pathogenic rs527236155 GRCh38 Chromosome 17, 21703384: 21703384
20 KCNJ18 NM_001194958.2(KCNJ18): c.1195C> T (p.Arg399Ter) single nucleotide variant Pathogenic rs527236156 GRCh37 Chromosome 17, 356346: 356346
21 KCNJ18 NM_001194958.2(KCNJ18): c.1195C> T (p.Arg399Ter) single nucleotide variant Pathogenic rs527236156 GRCh38 Chromosome 17, 21703981: 21703981
22 KCNJ18 NM_001194958.2(KCNJ18): c.1219C> T (p.Gln407Ter) single nucleotide variant Pathogenic rs527236157 GRCh37 Chromosome 17, 356370: 356370
23 KCNJ18 NM_001194958.2(KCNJ18): c.1219C> T (p.Gln407Ter) single nucleotide variant Pathogenic rs527236157 GRCh38 Chromosome 17, 21704005: 21704005

Expression for Thyrotoxic Periodic Paralysis

Search GEO for disease gene expression data for Thyrotoxic Periodic Paralysis.

Pathways for Thyrotoxic Periodic Paralysis

Pathways related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 26)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.75 ATP1A1 ATP1A2 ATP1B1 ATP1B2 CACNA1S KCNJ2
2
Show member pathways
12.7 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
3
Show member pathways
12.68 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
4
Show member pathways
12.61 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
5
Show member pathways
12.56 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
6
Show member pathways
12.45 ATP1A1 ATP1A2 ATP1B1 ATP1B2 GABRA3
7
Show member pathways
12.39 ADRB2 ATP1B1 ATP1B2 CACNA1S
8 12.15 CACNA1S KCNJ16 KCNJ2
9
Show member pathways
12.03 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
10 12 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
11
Show member pathways
11.91 GABRA3 KCNJ16 KCNJ2
12 11.9 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
13
Show member pathways
11.86 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
14 11.76 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
15 11.63 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
16 11.6 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
17 11.58 ADRB2 CACNA1S KCNJ2
18 11.55 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
19 11.5 ADRB2 ATP1A1 KCNJ2
20 11.47 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
21
Show member pathways
11.44 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
22 11.29 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
23 11.27 ADRB2 TSHR
24 11.15 ADRB2 TSHR
25 11.04 ATP1B1 ATP1B2
26 10.92 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4

GO Terms for Thyrotoxic Periodic Paralysis

Cellular components related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 apical plasma membrane GO:0016324 9.8 ADRB2 ATP1A1 ATP1B1 ATP1B2
2 basolateral plasma membrane GO:0016323 9.71 ATP1A1 ATP1B1 KCNJ16 TSHR
3 myelin sheath GO:0043209 9.69 ATP1A1 ATP1A2 ATP1B1
4 caveola GO:0005901 9.63 ATP1A1 ATP1A2 ATP1B1
5 sarcolemma GO:0042383 9.62 ATP1A1 ATP1A2 ATP1B1 CACNA1S
6 extracellular vesicle GO:1903561 9.61 ATP1A1 ATP1A2 ATP1B1
7 intercalated disc GO:0014704 9.46 ATP1A1 ATP1A2 ATP1B1 KCNJ2
8 T-tubule GO:0030315 9.26 ATP1A1 ATP1A2 CACNA1S KCNJ2
9 sodium:potassium-exchanging ATPase complex GO:0005890 9.02 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
10 membrane GO:0016020 10.26 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
11 plasma membrane GO:0005886 10.11 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 CACNA1S
12 integral component of membrane GO:0016021 10.03 ADRB2 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4

Biological processes related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

(show all 32)
# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.96 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 CACNA1S
2 sodium ion transport GO:0006814 9.91 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4
3 regulation of ion transmembrane transport GO:0034765 9.85 CACNA1S KCNJ16 KCNJ18 KCNJ2
4 cellular sodium ion homeostasis GO:0006883 9.8 ATP1A1 ATP1A2 ATP1B1 ATP1B2
5 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.78 ATP1A1 ATP1A2 ATP1B1 ATP1B2
6 cellular response to mechanical stimulus GO:0071260 9.77 ATP1A1 ATP1A2 KCNJ2
7 cell communication by electrical coupling involved in cardiac conduction GO:0086064 9.76 ATP1A1 ATP1A2 ATP1B1 ATP1B2
8 potassium ion transport GO:0006813 9.76 ATP1A1 ATP1A2 ATP1B1 ATP1B2 ATP1B4 KCNJ16
9 sodium ion export across plasma membrane GO:0036376 9.73 ATP1A1 ATP1A2 ATP1B1 ATP1B2
10 cellular potassium ion homeostasis GO:0030007 9.72 ATP1A1 ATP1A2 ATP1B1 ATP1B2 KCNJ2
11 regulation of cardiac muscle cell contraction GO:0086004 9.71 ATP1A1 ATP1A2 KCNJ2
12 relaxation of cardiac muscle GO:0055119 9.71 ATP1A1 ATP1A2 ATP1B1 KCNJ2
13 membrane repolarization during cardiac muscle cell action potential GO:0086013 9.7 ATP1A1 ATP1B1 KCNJ2
14 membrane repolarization GO:0086009 9.67 ATP1A1 ATP1A2 ATP1B1 ATP1B2
15 cardiac muscle contraction GO:0060048 9.65 ATP1A2 ATP1B1
16 positive regulation of ATPase activity GO:0032781 9.65 ATP1B1 ATP1B2
17 ATP metabolic process GO:0046034 9.65 ATP1A2 ATP1B1
18 activation of adenylate cyclase activity GO:0007190 9.64 ADRB2 TSHR
19 ATP hydrolysis coupled proton transport GO:0015991 9.64 ATP1A1 ATP1A2
20 regulation of the force of heart contraction GO:0002026 9.63 ATP1A1 ATP1A2
21 regulation of smooth muscle contraction GO:0006940 9.63 ADRB2 ATP1A2
22 regulation of sodium ion transport GO:0002028 9.62 ADRB2 ATP1A1
23 cardiac muscle cell action potential involved in contraction GO:0086002 9.62 ATP1A1 KCNJ2
24 cellular response to steroid hormone stimulus GO:0071383 9.61 ATP1A1 ATP1A2
25 membrane depolarization during cardiac muscle cell action potential GO:0086012 9.61 ATP1A2 KCNJ2
26 negative regulation of heart contraction GO:0045822 9.6 ATP1A1 ATP1A2
27 positive regulation of potassium ion import GO:1903288 9.58 ATP1B1 ATP1B2
28 positive regulation of potassium ion transmembrane transporter activity GO:1901018 9.58 ATP1B1 ATP1B2
29 positive regulation of sodium ion export across plasma membrane GO:1903278 9.57 ATP1B1 ATP1B2
30 response to glycoside GO:1903416 9.56 ATP1A1 ATP1A2
31 potassium ion import GO:0010107 9.5 ATP1A1 ATP1A2 ATP1B1 ATP1B2 KCNJ16 KCNJ18
32 potassium ion import across plasma membrane GO:1990573 9.17 ATP1A1 ATP1A2 ATP1B1 ATP1B2 KCNJ16 KCNJ18

Molecular functions related to Thyrotoxic Periodic Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 voltage-gated ion channel activity GO:0005244 9.62 CACNA1S KCNJ16 KCNJ18 KCNJ2
2 ATPase activator activity GO:0001671 9.43 ATP1B1 ATP1B2
3 inward rectifier potassium channel activity GO:0005242 9.43 KCNJ16 KCNJ18 KCNJ2
4 G-protein activated inward rectifier potassium channel activity GO:0015467 9.4 KCNJ16 KCNJ2
5 steroid hormone binding GO:1990239 9.37 ATP1A1 ATP1A2
6 potassium ion binding GO:0030955 9.33 ATP1A1 ATP1A2 ATP1B1
7 sodium ion binding GO:0031402 9.13 ATP1A1 ATP1A2 ATP1B1
8 sodium:potassium-exchanging ATPase activity GO:0005391 8.92 ATP1A1 ATP1A2 ATP1B1 ATP1B2

Sources for Thyrotoxic Periodic Paralysis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....